1
|
Rijken A, Galanos LJK, Burger JWA, Nienhuijs SW, van Erning FN, de Hingh IHJT. Peritoneal Metastases from Extraperitoneal Primary Tumors: Incidence, Treatment, and Survival from a Nationwide Database. Indian J Surg Oncol 2023; 14:60-66. [PMID: 37359924 PMCID: PMC10284768 DOI: 10.1007/s13193-022-01592-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2022] [Accepted: 07/12/2022] [Indexed: 11/29/2022] Open
Abstract
The objective of this study was to assess the incidence, treatment, and survival of patients with synchronous peritoneal metastases (PM) from extraperitoneal primary tumors. A cohort was selected from the Netherlands Cancer Registry (NCR), in which all patients diagnosed with PM in 2017 and 2018 were screened for eligibility. The five most common primary extraperitoneal origins of PM were included for further analyses: lung, breast, urinary tract, and kidney cancer and malignant melanoma. Survival was investigated using log-rank test between different primary tumor locations. In total, 480 patients were diagnosed with synchronous PM from extraperitoneal origins. The proportion of patients with PM per extraperitoneal origin ranged between 0.1 and 1.1%, with the highest proportion in lung cancer patients. Of all patients, 234 (49%) received tumor-directed treatment and 246 (51%) received no tumor-directed treatment. Survival in patients with PM from lung, breast, urinary tract, and kidney cancer and malignant melanoma was 1.6 months, 15.7 months, 5.4 months, 3.4 months, and 2.1 months, respectively (p < 0.001). In this study, a small, although significant number of patients with extraperitoneal cancer developed PM. The reported survival in patients with PM ranged between 1.6 and 15.7 months. Only half of the patients with PM received tumor-directed treatment and survival in patients without tumor-directed treatment was only 1.2 months. These findings are stressing the need to explore new diagnostic tools that may enable earlier diagnosis of PM and may potentially lead to a more effective treatment.
Collapse
Affiliation(s)
- Anouk Rijken
- Department of Surgery, Catharina Cancer Institute, PO Box 1350, 5602 ZA Eindhoven, Netherlands
- Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands
| | - Laskarina J. K. Galanos
- Department of Surgery, Catharina Cancer Institute, PO Box 1350, 5602 ZA Eindhoven, Netherlands
| | - Jacobus W. A. Burger
- Department of Surgery, Catharina Cancer Institute, PO Box 1350, 5602 ZA Eindhoven, Netherlands
| | - Simon W. Nienhuijs
- Department of Surgery, Catharina Cancer Institute, PO Box 1350, 5602 ZA Eindhoven, Netherlands
| | - Felice N. van Erning
- Department of Surgery, Catharina Cancer Institute, PO Box 1350, 5602 ZA Eindhoven, Netherlands
- Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands
| | - Ignace H. J. T. de Hingh
- Department of Surgery, Catharina Cancer Institute, PO Box 1350, 5602 ZA Eindhoven, Netherlands
- Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands
- GROW - School for Oncology and Development Biology, Maastricht University, Maastricht, the Netherlands
| |
Collapse
|
2
|
KÖMÜRCÜ Karuserci Ö, SUCU S, ÖĞÜT B, ERKILIÇ S, BALAT Ö. Kutanöz malign melanomanın peritoneal karsinomatozisi: Çok nadir görülen bir olgu sunumu ve literatür taraması. EGE TIP DERGISI 2019. [DOI: 10.19161/etd.470610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
3
|
Kömürcü Karuserci Ö, Sucu S, Öğüt B, Erkılıç S, Balat Ö. Kutanöz malign melanomanın peritoneal karsinomatozisi: Çok nadir görülen bir olgu sunumu ve literatür taraması. EGE TIP DERGISI 2019. [DOI: 10.19161/etd.665468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
4
|
Flanagan M, Solon J, Chang K, Deady S, Moran B, Cahill R, Shields C, Mulsow J. Peritoneal metastases from extra-abdominal cancer – A population-based study. Eur J Surg Oncol 2018; 44:1811-1817. [DOI: 10.1016/j.ejso.2018.07.049] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2018] [Revised: 05/10/2018] [Accepted: 07/02/2018] [Indexed: 01/30/2023] Open
|
5
|
Terhorst D, Radke C, Trefzer U. Ultra-late recurrence of malignant melanoma after a disease-free interval of 41 years. Clin Exp Dermatol 2011; 35:e20-1. [PMID: 20500162 DOI: 10.1111/j.1365-2230.2009.03330.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- D Terhorst
- Department of Dermatology and Allergy, Skin Cancer Center, Charité Medical University Berlin, Berlin, Germany.
| | | | | |
Collapse
|